JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway

Business by 2FIRSTS
Jun.06.2024
JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway
JSTE Technology Mr. Liu De Wen responds to JFT's creditor letter, claiming it contains falsehoods. The full statement follows.

On June 6th at noon, Mr. Liu Dewen, the head of JSTE Electronic Technology (Dongguan) Co., Ltd., publicly responded to the "Letter to Creditors" released by JFT, stating that the letter contained falsehoods.

 

The complete response is as follows:

 

JFT Company confirmed in a December 2021 email that they had acquired a 50% stake in our JSTE factory, but they suddenly changed their minds in September 2022 and decided to sell their stake instead of acquiring it. They officially exited JSTE in January 2023 and received a significant amount of money from the stock transfer.

During the equity exit process, JFT company confirmed the value of over 60 million worth of JUSTFOG brand e-cigarettes under the original processing agreement, but they have been delaying payment and not taking delivery. After several months of dragging their feet, they suddenly notified of the termination of the processing partnership, leaving Jest in a difficult situation.

 

However, the European agents of JFT company continue to authorize domestic licensed trading companies to request small batches of JUSTFOG branded e-cigarettes for sale. Unfortunately, this led to a criminal charge of trademark infringement by JFT, claiming that the e-cigarettes produced under the original agreement were unauthorized. The malicious intent behind this action is surprising, and this absurdity cannot be justified. Jast company reserves the right to hold the criminal plaintiff accountable for their legal responsibility.

 

Subsequently, Jast Company employed legal methods such as litigation and arbitration to seek compensation, and successfully obtained an injunction to preserve JFT Company’s registered trademarks (such as JUSTFOG) in China, as well as its fully-owned subsidiary’s bank accounts and patents related to the e-cigarette business in China. The breach of contract case is scheduled to be heard in the near future.

 

At the same time, Gest also filed a patent confirmation lawsuit to the court. During the cooperation between both parties, JFT appointed a research and development manager who established a labor relationship with Gest, and transferred numerous patents to its wholly-owned subsidiary, severely infringing on Gest's rights.

 

As a leading media and think tank in the field of atomization technology, 2FIRSTS closely monitors the latest developments on this issue and maintains contact with various parties.


 

Click on the image to read: "Vape Debt Risk: How can the operational difficulties of a single company affect the entire industry chain?"

 

JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway

 

Click on the image to read: JSTE Electronic Technology (Dongguan) Co., Ltd. Announces Liquidation

 

JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway
Click on the image to read: JSTE Electronic Technology (Dongguan) Co., Ltd. Announces Liquidation

 

Click on the image to read: "JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations".

 

JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway
Click on the image to read: "JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations"

 

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Editorial says West Virginia’s HB 5437 “Vape Safety Act” goes too far, targeting residency and citizenship provisions
Editorial says West Virginia’s HB 5437 “Vape Safety Act” goes too far, targeting residency and citizenship provisions
A News and Sentinel editorial argues that West Virginia’s HB 5437, the “Vape Safety Act,” goes beyond reasonable regulation by adding provisions barring any part of a vape or smoke shop from being used as a residence and requiring owners to be U.S. citizens.
Feb.27 by 2FIRSTS.ai
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
U.S. International Trade Commission has refused to pause the import and sales bans imposed on cannabis vape company Stiiizy while it appeals the agency’s patent infringement ruling in its dispute with Pax Labs.
Apr.07 by 2FIRSTS.ai
Alaska AG warns 1,500+ retailers to stop selling unauthorized vapes and nicotine pouches
Alaska AG warns 1,500+ retailers to stop selling unauthorized vapes and nicotine pouches
Alaska’s attorney general has sent warning letters to more than 1,500 retailers and distributors, cautioning them against selling tobacco products — including e-cigarettes and oral nicotine pouches — that lack U.S. Food and Drug Administration authorization.
Mar.06 by 2FIRSTS.ai
New York Says Seized Illegal Vape Shipment Had Retail Value of USD 2.2 Million to USD 3.5 Million
New York Says Seized Illegal Vape Shipment Had Retail Value of USD 2.2 Million to USD 3.5 Million
New York state health officials said a joint operation last week involving the State Department of Health, Nassau County police and local health officials intercepted about 14 tons of illegal vape products that were intended for local distributors and smoke shops.
Mar.20 by 2FIRSTS.ai
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11